LIFE AND DEATH OF SPARE (SELECTIVE BLADDER PRESERVATION AGAINST RADICAL EXCISION): REFLECTIONS ON WHY THE SPARE TRIAL CLOSED-Reference-Cited by-同舟云学术

LIFE AND DEATH OF SPARE (SELECTIVE BLADDER PRESERVATION AGAINST RADICAL EXCISION): REFLECTIONS ON WHY THE SPARE TRIAL CLOSED

Published:2010-08-12 Issue:6 Volume:106 Page:753-755
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Huddart Robert A.,Hall Emma,Lewis Rebecca,Birtle Alison,

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2010.09537.x/fullpdf

Reference4 articles.

1. Quality improvement report: improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study;Donovan;BMJ,2002

2. Moynihan C Hall E Lewis R Birtle A Mead GM Huddart R SPARE: a qualitative study investigating randomisation barriers in a Selective Bladder Preservation trial (SBP) (ISCRCTN. 61126465) American Society of Clinical Oncology Annual Meeting 2009

3. Moynihan C Hall E Lewis R et al SPARE: a qualitative study investigating randomisation barriers in a Selective Bladder Preservation Trial (SBP) (ISCRCTN. 61126465; CRUK/07/011). National Cancer Research Institute Annual Conference 2009

4. Lewis R Huddart R Birtle A Blazeby J Jones E Hall E Challenges of identifying cancer patients for randomised controlled trials from urology clinics - what lessons can we learn from SPARE? National Cancer Research Institute Annual Conference 2009

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT Experience;Current Oncology;2024-08-21

2. Kann beim muskelinvasiven Urothelkarzinom der Harnblase zukünftig auf die Zystektomie verzichtet werden?;Die Urologie;2024-08-14

3. Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older;Frontiers in Oncology;2024-05-15

4. Blasenerhaltende multimodale Therapiekonzepte;TumorDiagnostik & Therapie;2024-03

5. Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer;Clinical Cancer Research;2023-11-01